HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Palliative Short-Course Radiation Therapy in Rectal Cancer: A Phase 2 Study.

AbstractPURPOSE:
The management of patients with symptomatic rectal cancer not amenable to curative treatment may be challenging. The aim of this phase 2 study was to evaluate the efficacy of short-course radiation therapy in patients with obstructing rectal cancer.
METHODS AND MATERIALS:
Patients who were not candidates for surgical resection because of synchronous metastases, age, and/or comorbidities were considered eligible. The sample size was calculated based on the 2-stage design of Simon. Short-course radiation therapy was delivered with an isocentric 4-field box technique (total, 25 Gy; 5 fractions in 5 days). Chemotherapy was suspended during radiation treatment. Clinical outcome measures were symptomatic response rate, toxicity, colostomy-free survival, and overall survival.
RESULTS:
From October 2003 to November 2012, 18 patients (median age, 77.5 years) were enrolled. The median follow-up was 11.5 months (range, 3-36 months). Four weeks after treatment, a complete response (ie, complete symptom resolution) was observed in 38.9% of patients and a partial response in 50.0% cases, whereas 11.1% had no response. The rates of reduction or resolution of pain and bleeding were 87.5% and 100%, respectively. The 1-, 2-, and 3-year colostomy-free survival rates were 100%, 71.4%, and 47.6%, respectively (median, 30 months). The 1-, 2-, and 3-year cumulative overall survival rates were 85.2%, 53%, and 39.8%, respectively (median, 25 months). No patients stopped treatment because of gastrointestinal or genitourinary toxicities: 38.9% of patients had grade 1 to 2 toxicity, and 16.7% had grade 3 toxicity. Only 1 patient had hematologic grade 2 toxicity, and 2 patients had grade 2 skin toxicity.
CONCLUSIONS:
Short-course radiation therapy may represent a safe and effective alternative treatment option in patients with obstructing rectal cancer not eligible for curative treatment, allowing colostomy to be avoided in a substantial proportion of patients.
AuthorsVincenzo Picardi, Francesco Deodato, Alessandra Guido, Lucia Giaccherini, Gabriella Macchia, Leonardo Frazzoni, Andrea Farioli, Dajana Cuicchi, Savino Cilla, Francesco Cellini, A F M Kamal Uddin, Maria Antonietta Gambacorta, Milly Buwenge, Andrea Ardizzoni, Gilberto Poggioli, Vincenzo Valentini, Lorenzo Fuccio, Alessio G Morganti
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 95 Issue 4 Pg. 1184-90 (07 15 2016) ISSN: 1879-355X [Electronic] United States
PMID27215449 (Publication Type: Clinical Trial, Phase II, Journal Article)
CopyrightCopyright © 2016 Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Colostomy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Palliative Care
  • Prospective Studies
  • Radiation Injuries (etiology)
  • Rectal Neoplasms (mortality, radiotherapy)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: